A Study in Healthy Men to Test How Different Doses of BI 3032950 Are Tolerated
Clinical trial NCT05518708 · COMPLETED
Trial details
- NCT number
- NCT05518708
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-27
- Primary completion
- 2023-09-21
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.